ReviewNature chemical biology2026
Emerging tools to investigate the contribution of selenium to ferroptosis and beyond.
Review in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Selenium has a paradoxical role in biology, being essential at trace levels yet toxic at slightly higher doses. To operate within this narrow range, organisms have developed specialized pathways for selenium uptake, transport and usage/storage, primarily through selenoprotein biosynthesis. This Review summarizes current understanding of selenium handling and selenoprotein production, and discusses how selenium metabolism shapes susceptibility to ferroptotic cell death. We highlight both the role of selenoproteins in cellular defense and the unexpected roles of small-molecule metabolites, such as hydrogen selenide. We further discuss recent progress in analytical and chemical approaches, including mass spectrometry, activity-based probes and synthetic selenium donors, which are beginning to enable direct interrogation of these transient species. Together, these developments position selenium metabolism as a dynamic, chemically tractable regulator of redox biology and a promising therapeutic target.
Identifiers
42552382What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.